Atlas Trials

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

Clinical trial NCT02362958 · COMPLETED

Trial details

NCT number
NCT02362958
Sponsor
Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HER2 Positive Breast Cancer
Start date
2015-01-09
Primary completion
2020-05-31
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.